Lightweight Modular Chest Freezer Rack
Micronic has added a Modular Vertical Freezer Rack to its extensive range of sample storage accessories for biobanking.
The Modular Freezer Rack provides a flexible and low cost solution for organising sample storage in a chest freezer. The lightweight modular storage system fits into all chest freezers and is fully compatible with all ANSI/SLAS standard footprint storage racks.
To set up the easy-to-use modular system simply click individual rack holders (height: 68 mm) together to construct a tower of up to 15 holders. Each rack holder has the capacity to house a single Micronic storage rack (Roborack-96, Comorack-96, Comorack-24 and Arctic Rack-24). When using the Micronic Loborack-96 with a low profile cover, one rack holder accommodates two Loboracks, providing a space saving storage solution. Manufactured from a special durable high grade plastic, Micronic Modular Vertical Freezer Racks are ideally constructed for long-term storage at ultra-low temperatures.
Compared with storing samples in an upright freezer, the main advantage of a chest freezer is that they are more energy efficient due to better cold air retention. In addition, to offering lower ongoing energy consumption chest freezers are typically less expensive to purchase and tend to have longer life cycles than upright models.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.